Follow-The-Filings

Security · featured owners

DGX Quest Diagnostics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 5 Owners
  • Max 1.4%
  • $333M
  • 1 new 1 add 1 reduce 1 exit

DGX (Quest Diagnostics Inc.) is held in 5 featured 13F books as of 2026 Q2. Christopher Davis - Davis Selected Advisers is the largest tracked holder by portfolio weight (1.4%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.4% (Christopher Davis - Davis Selected Advisers) · not free-float ownership

  1. Christopher Davis reduce 1.4%
  2. Kentucky Trust Co. 0.15%
  3. Murray Stahl 0.01%
  4. Steven Check new 0.01%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Christopher Davis - Davis Selected Advisers 2026 Q2 1.4% Reduce −3.8% 1,555,612 $330M history
First Eagle Investment Management 2026 Q2 <0.01% Add +153.5% 7,606 $2M history
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 0.01% Hold 2,900 $615K history
Kentucky Trust Co. - Kentucky Trust 2026 Q2 0.15% Hold 1,506 $319K history
Steven Check - Check Capital Management 2026 Q2 0.01% New 0.01% 1,300 $276K history
Lee Ainslie - Maverick Capital exited 2026 Q2 last 2026 Q1 0.01% Exit −0.01% 2,756 $540K history

5 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 9 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
424B2 Filing Doc
424B2 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 28, 2026 Filing Doc
4 Period Jul 28, 2026 Filing Doc
4 Period Jul 22, 2026 · 8 forms Filing Doc
4 Period Jul 1, 2026 Filing Doc
4 Period Jun 4, 2026 Filing Doc
4 Period Jun 1, 2026 Filing Doc
4 Period May 20, 2026 · 10 forms Filing Doc
4 Period Apr 20, 2026 Filing Doc

Updated 11 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $9.25B $9.87B $11.04B
Gross profit * $3.05B $3.24B $3.66B
Gross margin * 33.0% 32.9% 33.2%
Net income $854M $871M $992M
Net margin * 9.2% 8.8% 9.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.37B $2.39B $2.38B
Total non-current assets * $11.65B $13.76B $13.85B
Total assets $14.02B $16.15B $16.22B
Total current liabilities $1.82B $2.17B $2.28B
Total equity $6.31B $6.78B $7.17B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $1.27B $1.33B $1.89B
Cash from investing -$1.06B -$2.55B -$0.631B
Cash from financing $0.16B $1.08B -$1.39B
Net change in cash $371M -$137M -$129M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders